FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

396046007: Ergotamine tartrate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1469986016 Ergotamine tartrate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1489672013 Ergotamine tartrate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
7351000188111 ergotamine tartrate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
809301000172116 tartrate d'ergotamine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ergotamine tartrate (substance) Is a Ergotamine (substance) false Inferred relationship Some
Ergotamine tartrate (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. A substance that is produced by a living organism and is toxic, noxious, or poisonous. true Inferred relationship Some
Ergotamine tartrate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Ergotamine (substance) true Inferred relationship Some
Ergotamine tartrate (substance) Is a Ergot alkaloid false Inferred relationship Some
Ergotamine tartrate (substance) Is a alcaloïde peptidique false Inferred relationship Some
Ergotamine tartrate (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Serotonin receptor agonist true Inferred relationship Some
Ergotamine tartrate (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Alpha adrenergic receptor agonist (disposition) true Inferred relationship Some
Ergotamine tartrate (substance) Is a Adrenergic receptor agonist false Inferred relationship Some
Ergotamine tartrate (substance) Is a Analgesic (substance) true Inferred relationship Some
Ergotamine tartrate (substance) Is a Substance with serotonin receptor agonist mechanism of action (substance) true Inferred relationship Some
Ergotamine tartrate (substance) Is a Alpha adrenergic receptor agonist false Inferred relationship Some
Ergotamine tartrate (substance) Is a Ergopeptide true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely caffeine 100 milligram and ergotamine tartrate 1 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ergotamine tartrate (substance) Inferred relationship Some
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ergotamine tartrate (substance) Inferred relationship Some
Ergotamine tartrate 2 mg sublingual tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ergotamine tartrate (substance) Inferred relationship Some
Product containing ergotamine tartrate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ergotamine tartrate (substance) Inferred relationship Some
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ergotamine tartrate (substance) Inferred relationship Some
Caffeine + ergotamine tartrate 100mg/1mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ergotamine tartrate (substance) Inferred relationship Some
Caffeine + ergotamine tartrate 100mg/2mg suppository (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ergotamine tartrate (substance) Inferred relationship Some
Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ergotamine tartrate (substance) Inferred relationship Some
Caffeine + ergotamine tartrate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ergotamine tartrate (substance) Inferred relationship Some
Product containing belladonna alkaloids and ergotamine tartrate and phenobarbital The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ergotamine tartrate (substance) Inferred relationship Some
Product containing ergotamine tartrate in oral dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ergotamine tartrate (substance) Inferred relationship Some
Ergotamine + caffeine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ergotamine tartrate (substance) Inferred relationship Some
Product containing caffeine and ergotamine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ergotamine tartrate (substance) Inferred relationship Some
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Ergotamine tartrate (substance) Inferred relationship Some 1
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ergotamine tartrate (substance) Inferred relationship Some 3
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Ergotamine tartrate (substance) Inferred relationship Some 3
Product containing precisely caffeine 100 milligram and ergotamine tartrate 1 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ergotamine tartrate (substance) Inferred relationship Some 2
Product containing precisely caffeine 100 milligram and ergotamine tartrate 1 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Ergotamine tartrate (substance) Inferred relationship Some 2
Product containing precisely caffeine 100 milligram and ergotamine tartrate 1 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Ergotamine tartrate (substance) Inferred relationship Some 1
Ergotamine tartrate 2 mg sublingual tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Ergotamine tartrate (substance) Inferred relationship Some 1
Ergotamine tartrate 2 mg sublingual tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ergotamine tartrate (substance) Inferred relationship Some 1
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Ergotamine tartrate (substance) Inferred relationship Some 2
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ergotamine tartrate (substance) Inferred relationship Some 2
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Ergotamine tartrate (substance) Inferred relationship Some 1
Product containing precisely caffeine 100 milligram and ergotamine tartrate 1 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Ergotamine tartrate (substance) Inferred relationship Some 1
Product containing precisely caffeine 100 milligram and ergotamine tartrate 1 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ergotamine tartrate (substance) Inferred relationship Some 2
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ergotamine tartrate (substance) Inferred relationship Some 3

This concept is not in any reference sets

Back to Start